Research Article
Biocurcumin as Radiosensitiser for Cervical Cancer Study (BRACES): A Double-Blind Randomised Placebo-Controlled Trial
Table 2
Characteristics of patients included in the study.
| | Characteristics | Total | BCM-95 (n = 61) | Placebo (n = 60) | value |
| | Age (year) | | | | 0.24 | | Min–max | 25–69 | 25–68 | 34–69 | | | Mean (SD) | 50.47 (8.69) | 49.2 (9.74) | 51 (7.96) | |
| | Educational level (%) | | | | 0.26 | | Under elementary graduate | 44 (36.3%) | 22 (36%) | 22 (35.5%) | | | Elementary–junior high school | 52 (43.3%) | 23 (37.7%) | 29 (49.1%) | | | >Senior high school | 25 (20.4%) | 16 (26.3%) | 9 (15.4%) | |
| | Preradiation BMI (kg/m 2 ) | | | | 0.68 | | Min–max | 15.4–35.7 | 15.4–35.7 | 16.8–30.6 | | | Mean (SD) | 23.9 (3.8) | 23.8 (4.22) | 24.1 (3.4) | |
| | Parity | | | | 0.98 | | Min–max | 0–11 | 0–9 | 0–11 | | | Median (variance) | 3 (4.6) | 3 (5.05) | 3 (4.55) | |
| | Creatinine (mg/dL) | | | | 0.43 | | ≤1.2 mg/dL | 97 (80.8%) | 51 (83.6%) | 46 (77.9%) | | | >1.2 mg/dL | 24 (19.2%) | 10 (16.4%) | 14 (22.1%) | |
| | Preradiation tumor size (mm) | | | | 0.31 | | Min–max | 25–176 | 30–107 | 25–176 | | | Median (variance) | 67.5 (555.6) | 69.5 (393.6) | 64 (739.6) | | | Mean+ (SD) | 4.1 (0.39) | 4.1 (0.31) | 4.1 (0.39) | 0.38 |
| | LVSI | | | | 0.144 | | Positive | 2 (1.7%) | 0 | 2 (3.4%) | | | Negative | 119 (98.3%) | 61 (100%) | 58 (96.6%) | |
| | Grade | | | | 0.68 | | Mild | 21 (17.3%) | 10 (16.3%) | 11 (18.3%) | | | Moderate | 87 (71.9%) | 43 (70.4%) | 44 (73.3%) | | | High | 13 (10.8%) | 8 (13.3%) | 5 (8.4%) | |
| | Radiation > 10 Gy | | | | 0.33 | | Min–max | 12–78.4 | 12–78.4 | 16–74 | | | Median (variance) | 71 (176.6) | 71 (219.8) | 71 (128.1) | |
|
|
